ホーム > 市場調査レポート > 医薬品

感染症パイプライン分析

市場調査レポート

商品コード

1741437

蚊媒介感染症市場：疾患タイプ別、治療タイプ別、エンドユーザー別、地域別

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

出版日: 2025年03月27日
発行: Coherent Market Insights
ページ情報: 英文 150 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 654,390円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,017,940円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,454,200円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.42円

全表示
概要
目次

概要

サンプル依頼リストに入れる

蚊媒介感染症市場は、2025年には35億8,000万米ドルと推定され、2032年には58億6,000万米ドルに達する見込みで、2025年から2032年までの年間平均成長率（CAGR）で7.3%の成長が予測されています。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	35億8,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	7.30%	2032年の価値予測	58億6,000万米ドル

蚊媒介感染症は、世界各地で公衆衛生上の重大な問題となっています。感染した蚊に刺されることで感染するこれらの病気は、人間の生命を脅かし、かなりの疾病負担の原因となっています。蚊媒介感染症と闘うための革新的な解決策のひとつが、蚊を寄せ付けない石板の開発です。この石板は蚊に対する効果的なバリアとして機能し、マラリア、デング熱、ジカウイルスなどの病気のリスクを軽減します。

市場力学：

世界の蚊媒介感染症市場は、蚊媒介感染症の発生率の増加と公衆衛生への影響に対する意識の高まりから、近い将来大きな成長が見込まれます。政府や医療機関は、効果的な診断法や治療法を開発するために研究開発に多額の投資を行っています。殺虫剤や蚊取り器といった蚊の駆除方法における技術の進歩が、市場の成長にさらに貢献しています。しかし、対処すべき課題もいくつかあります。市場成長の主な抑制要因の1つは、特に新興諸国において、医療施設に対する認識やアクセスが不足していることです。限られた医療インフラ、不十分な資金、劣悪な衛生環境が蚊媒介感染症の蔓延を助長しています。さらに、蚊の薬剤耐性の開発やワクチン開発の複雑さは、市場にとって大きな課題となっています。

こうした課題にもかかわらず、世界の蚊媒介感染症市場には大きなチャンスがあります。新たな診断ツール、治療薬、ワクチンの開発は、潜在的な成長の見込みを提供します。さらに、製薬会社、研究機関、政府間の協力や提携により、蚊の駆除や予防のための革新的なソリューションの開発が加速するものと思われます。

本調査の主な特徴

本レポートでは、世界の蚊媒介感染症市場を詳細に分析し、2024年を基準年とした予測期間2025年～2032年の市場規模および年間平均成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界の蚊媒介感染症市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて掲載しています。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
蚊媒介感染症の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の蚊媒介感染症市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

GlaxoSmithKline plc
Sanofi S.A.
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson
Eisai Co., Ltd
Takeda Pharmaceutical Company Limited
AstraZeneca
Valeant Pharmaceuticals International, Inc.
Mitsubishi Tanabe Pharma Corporation
Abbott
Hoffmann-La Roche Ltd
Sun Pharmaceutical Industries Ltd
Lupin Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Serum Institute of India Pvt. Ltd.
CSL Limited
Teva Pharmaceutical Industries Ltd

第10章セクション

調査手法
出版社について

Product Code: CMI6241

Mosquito Borne Disease Market is estimated to be valued at USD 3.58 Bn in 2025 and is expected to reach USD 5.86 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.58 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.30%	2032 Value Projection:	USD 5.86 Bn

Mosquito borne disease have been a significant public health concern in several parts of the world. These diseases, transmitted through the bite of infected mosquitoes, pose a threat to human lives, and are responsible for a considerable disease burden. One innovative solution to combat mosquito borne diseases is the development of a stone slab that repels mosquitoes, and thus, offering protection to individuals. This stone slab acts as an effective barrier against mosquitoes, reducing the risk of diseases such as malaria, dengue fever, and Zika virus.

Market Dynamics:

Global mosquito borne disease market is expected to witness significant growth in the near future due to increasing incidence of mosquito-borne diseases, coupled with growing awareness about their impact on public health. Governments and healthcare organizations are investing heavily in research and development to develop effective diagnostics and treatment options. Technological advancements in mosquito control methods such as insecticides and mosquito traps are further contributing to market growth. However, there are also several challenges that need to be addressed. One of the major restraints for the market growth is the lack of awareness and access to healthcare facilities, particularly in developing countries. Limited healthcare infrastructure, inadequate funding, and poor sanitation contribute to the spread of mosquito-borne diseases. Furthermore, the development of drug resistance in mosquitoes and the complexity of vaccine development pose significant challenges to the market.

Despite these challenges, there are significant opportunities in the global mosquito borne disease market. The development of new diagnostic tools, therapeutic drugs, and vaccines offers potential growth prospects. Moreover, collaborations and partnerships between pharmaceutical companies, research institutions, and governments are likely to accelerate the development of innovative solutions for mosquito control and prevention.

Key features of the study:

This report provides in-depth analysis of the global mosquito borne disease market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global mosquito borne disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca, Valeant Pharmaceuticals International, Inc., Mitsubishi Tanabe Pharma Corporation, Abbott , F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, and Teva Pharmaceutical Industries Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global mosquito borne disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mosquito borne disease market

Mosquito Borne Disease Market Detailed Segmentation:

By Disease Type:
- Malaria
- Dengue
- Yellow Fever
- West Nile Virus
- Chikungunya
- Zika Virus
- Others
By Treatment Type:
- Medication
- Vaccination
- Vector Control Methods
- Immunotherapy
- Supportive Care
- Others
By End User:
- Hospitals
- Clinics
- Diagnostic Centers
- Research Institutes
- Government Organizations
- NGOs
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc
- Sanofi S.A.
- Pfizer Inc.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
- Eisai Co., Ltd
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Valeant Pharmaceuticals International, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Abbott
- F.Hoffmann-La Roche Ltd
- Sun Pharmaceutical Industries Ltd
- Lupin Pharmaceuticals, Inc.
- BioCryst Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Serum Institute of India Pvt. Ltd.
- CSL Limited
- Teva Pharmaceutical Industries Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Mosquito Borne Disease, By Disease Type
- Market Mosquito Borne Disease, By Treatment Type
- Market Mosquito Borne Disease, By End User
- Market Mosquito Borne Disease, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Malaria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Dengue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
West Nile Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Chikungunya
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Zika Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vector Control Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bin)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Supportive Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
NGOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eisai Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Valeant Pharmaceuticals International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mitsubishi Tanabe Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioCryst Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

ライセンス / 価格

PDF (Single User License)

USD 4,500 654,390円

その他のライセンス / 価格

PDF (Multi User License)

USD 7,000 1,017,940円

PDF (Enterprise User License)

USD 10,000 1,454,200円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.42円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

蚊媒介

蚊媒介感染症市場：疾患タイプ別、治療タイプ別、エンドユーザー別、地域別

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の蚊媒介感染症市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章世界の蚊媒介感染症市場、疾患タイプ別、2020年～2032年

第6章世界の蚊媒介感染症市場、治療タイプ別、2020年～2032年

第7章世界の蚊媒介感染症市場、エンドユーザー別、2020年～2032年

第8章世界の蚊媒介感染症市場、地域別、2020年～2032年

第9章競合情勢

第10章セクション

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

蚊媒介感染症市場：疾患タイプ別、治療タイプ別、エンドユーザー別、地域別

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の蚊媒介感染症市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章 世界の蚊媒介感染症市場、疾患タイプ別、2020年～2032年

第6章 世界の蚊媒介感染症市場、治療タイプ別、2020年～2032年

第7章 世界の蚊媒介感染症市場、エンドユーザー別、2020年～2032年

第8章 世界の蚊媒介感染症市場、地域別、2020年～2032年

第9章 競合情勢

第10章 セクション

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の蚊媒介感染症市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章世界の蚊媒介感染症市場、疾患タイプ別、2020年～2032年

第6章世界の蚊媒介感染症市場、治療タイプ別、2020年～2032年

第7章世界の蚊媒介感染症市場、エンドユーザー別、2020年～2032年

第8章世界の蚊媒介感染症市場、地域別、2020年～2032年

第9章競合情勢

第10章セクション